Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.

Nucleic Acids Res.. 2018; 
Fischbach Arthur,Krüger Annika,Hampp Stephanie,Assmann Greta,Rank Lisa,Hufnagel Matthias,St?ckl Martin T,Fischer Jan M F,Veith Sebastian,Rossatti Pascal,Ganz Magdalena,Ferrando-May Elisa,Hartwig Andrea,Hauser Karin,Wiesmüller Lisa,Bürkle Alexander,Mangerich A
Products/Services Used Details Operation
Peptide Synthesis during dialysis. PAR overlay assay 168–403 pmol of custom-synthesized peptides (Genscript) or 5 pmol Get A Quote

摘要

The post-translational modification poly(ADP-ribosyl)ation (PARylation) plays key roles in genome maintenance and transcription. Both non-covalent poly(ADP-ribose) binding and covalent PARylation control protein functions, however, it is unknown how the two modes of modification crosstalk mechanistically. Employing the tumor suppressor p53 as a model substrate, this study provides detailed insights into the interplay between non-covalent and covalent PARylation and unravels its functional significance in the regulation of p53. We reveal that the multifunctional C-terminal domain (CTD) of p53 acts as the central hub in the PARylation-dependent regulation of p53. Specifically, p53 bound to auto-PARylated ... More

关键词

XML 地图